Guller Ulrich, Zajac Paul, Schnider Annelies, Bösch Beatrix, Vorburger Stefan, Zuber Markus, Spagnoli Giulio Cesare, Oertli Daniel, Maurer Robert, Metzger Urs, Harder Felix, Heberer Michael, Marti Walter Richard
Surgical Research Unit, Deparment of Surgery, University of Basel, Switzerland.
Ann Surg. 2002 Dec;236(6):768-75; discussion 775-6. doi: 10.1097/00000658-200212000-00009.
To evaluate the clinical relevance of real-time quantitative polymerase chain reaction (qPCR) detection of CEA and CK20 transcripts, as potentially related to tumor cell dissemination, in blood and peritoneal lavage from patients undergoing surgery for colorectal cancer.
Dissemination of single colorectal cancer cells in the peritoneal cavity, as well as in tumor drainage and peripheral blood vessels, might play a role in the metastasis process, thus affecting the clinical course. However, this phenomenon needs further elucidation.
In a prospective study the authors evaluated the potential of qPCR in the detection of CEA and/or CK20 transcripts in the peritoneal lavage fluid and in the peripheral and mesenteric venous blood of 39 patients undergoing curative resection for colorectal cancer. Peritoneal lavage and peripheral blood was sampled before and after tumor resection; mesenteric venous blood was sampled from the major tumor-draining vein immediately before clamping. After RNA extraction and reverse transcription, qPCR was performed using specific cDNA primers and probes for CEA and CK20. The dichotomous results from the qPCR were used as a predictor along with other covariates in Cox proportional hazard regression models of long-term outcome (disease-free survival and overall survival).
Of 39 patients, 11 were positive. The median follow-up at analysis was 31 months for all patients. The dichotomous qPCR covariate was significant, with P =.001 and.0035 for disease-free survival and overall survival, respectively, in the proportional hazard regression models with only qPCR. In seven patients, disseminated colorectal cancer cells were found in the peritoneal lavage fluid but not in blood specimens; five of these patients (71%) had recurrence.
These data suggest that detection of mRNA coding for CEA and/or CK20 using qPCR has potential clinical utility as a prognostic marker and should be evaluated in larger clinical studies. Identification of patients at high risk for metastatic disease after curative resection of colorectal cancer might be improved by analyzing peritoneal lavage specimens in addition to blood samples. This is based on the observation that in more than half of qPCR-positive patients, disseminated colorectal cancer cells were detected in peritoneal lavage specimens but not in blood samples, and that 71% of them had recurrence.
评估实时定量聚合酶链反应(qPCR)检测接受结直肠癌手术患者血液和腹腔灌洗液中癌胚抗原(CEA)和细胞角蛋白20(CK20)转录本的临床相关性,这可能与肿瘤细胞播散有关。
单个结直肠癌细胞在腹腔以及肿瘤引流和外周血管中的播散可能在转移过程中起作用,从而影响临床病程。然而,这一现象需要进一步阐明。
在一项前瞻性研究中,作者评估了qPCR检测39例接受结直肠癌根治性切除术患者腹腔灌洗液、外周血和肠系膜静脉血中CEA和/或CK20转录本的潜力。在肿瘤切除前后采集腹腔灌洗液和外周血;在夹闭前立即从主要肿瘤引流静脉采集肠系膜静脉血。RNA提取和逆转录后,使用针对CEA和CK20的特异性cDNA引物和探针进行qPCR。qPCR的二分结果与其他协变量一起用作长期结局(无病生存期和总生存期)Cox比例风险回归模型的预测指标。
39例患者中,11例呈阳性。分析时所有患者的中位随访时间为31个月。在仅包含qPCR的比例风险回归模型中,qPCR二分协变量具有显著性,无病生存期和总生存期的P值分别为0.001和0.0035。7例患者腹腔灌洗液中发现播散的结直肠癌细胞,但血液标本中未发现;其中5例患者(71%)复发。
这些数据表明,使用qPCR检测编码CEA和/或CK20的mRNA作为预后标志物具有潜在临床应用价值,应在更大规模的临床研究中进行评估。除血液样本外,分析腹腔灌洗标本可能有助于提高结直肠癌根治性切除术后转移疾病高危患者的识别。这是基于以下观察结果:超过一半的qPCR阳性患者腹腔灌洗标本中检测到播散的结直肠癌细胞,但血液样本中未检测到,且其中71%的患者复发。